相关实验视频
Updated: Jul 10, 2025

13:25
Acute Kidney Injury Model Induced by Cisplatin in Adult Zebrafish
Published on: May 15, 2021
5.8K
含有西斯普拉丁的化学疗法的水化方法:系统性审查
Charlotte Sikking1, Kelly L Niggebrugge-Mentink2, A S Elise van der Sman3
1Department of Clinical Pharmacy, Albert Schweitzer Hospital, Dordrecht, The Netherlands.
The oncologist
|November 23, 2023
概括
最佳的西斯普拉丁水合包括短时间,低体积的液体与曼尼托和的管理,以防止脏损伤 (毒性). 需要进一步的研究来比较利尿剂并确定最佳的曼尼托和剂量.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 西斯普拉丁化疗可能会导致损伤 (毒性).
- 预防性水化策略至关重要,但没有标准化.
- 这项研究审查了证据,以优化水化方案,以预防西斯普拉丁诱导的毒性 (CIN).
结论:
- 对于思普拉丁来说,最佳的水化需要短时间和有限的体积.
- 建议包括曼尼托和.
- 需要进一步的对比试验来比较利尿剂,并确定最佳的曼尼托尔/剂量.
更多相关视频
相关概念视频
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
215
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
215
Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
169
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
169

